Table 5:
Characteristics of patients in the Flatiron Health mUC cohort by treatment type.
| Carboplatin-Based Chemotherapy | Immunotherapy | ||
|---|---|---|---|
| N = 1600 | N = 587 | ||
| Age, mean (SD) | 72.56 (8.48) | 74.74 (8.75) | |
| Gender, N (% Male) | 1171 (73.2) | 427 (72.7) | |
| Race/Ethnicity N (%) | White | 1213 (75.8) | 437 (74.4) |
| Asian | 23 (1.4) | 4 (0.7) | |
| Black or African American | 75 (4.7) | 21 (3.6) | |
| Hispanic or Latino | 71 (4.4) | 23 (3.9) | |
| Other Race | 99 (6.2) | 35 (6.0) | |
| Unknown | 119 (7.4) | 67 (11.4) | |
| Baseline Year N (%) | 2011 | 110 (6.9) | 0 (0.0) |
| 2012 | 165 (10.3) | 0 (0.0) | |
| 2013 | 224 (14.0) | 0 (0.0) | |
| 2014 | 238 (14.9) | 0 (0.0) | |
| 2015 | 283 (17.7) | 8 (1.4) | |
| 2016 | 308 (19.2) | 101 (17.2) | |
| 2017 | 195 (12.2) | 283 (48.2) | |
| 2018 | 77 (4.8) | 195 (33.2) | |
| Primary Site N (%) | Bladder | 1185 (74.1) | 444 (75.6) |
| Renal Pelvis | 263 (16.4) | 75 (12.8) | |
| Ureter | 140 (8.8) | 65 (11.1) | |
| Urethra | 12 (0.8) | 3 (0.5) | |
| Smoking Status N (%) | History of smoking | 1145 (71.6) | 434 (73.9) |
| No history of smoking | 419 (26.2) | 147 (25.0) | |
| Unknown/not documented | 36 (2.2) | 6 (1.0) | |
| 1 year comorbidity score, mean (SD) | 0.90 (2.67) | 1.86 (4.03) | |